StockData
Can-Fite BioPharma Ltd. logo

Can-Fite BioPharma Ltd. (CANF) income statement

CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 1/30
$1.51−0.02 (-1.31%)

Close on Nov 18, 2026Market cap $1.98MP/E –Yield –

Can-Fite BioPharma Ltd. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
–
Operating margin
-2456.8%
Net margin
-2426.7%
Return on equity, FY2025
-178.2%

Financial strength

Current ratio
3.60
Debt to equity
–
Debt to assets
–
Cash to current liabilities
134.2%

Valuation

P/E ratio
–
Price to sales
4.88
Price to book
0.41
Dividend yield
–

See a number that looks wrong?